Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
21St Century Medical Technologies LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner, suggesting a focused prosecution strategy. The company's work is concentrated in 1 distinct art unit, which limits the administrative complexity of their patent portfolio at the USPTO.
The busiest examiner, VU, JAKE MINH, is managing the 1 busiest examiner pending action for the company. Since there is only 1 distinct examiner involved, the company's immediate patent goals are subject to the specific scrutiny of this single official. This concentration in the Biotechnology & Pharmaceuticals area allows the practitioner to focus on the technical requirements of VU, JAKE MINH without other competing actions.
With 1 pending office action, the company's current workload is highly centralized. The presence of 1 distinct art unit ensures that the examination follows a consistent set of divisional guidelines. For the practitioner, this means that the 1 pending office action can be addressed with a strategy that is specifically tailored to the preferences of VU, JAKE MINH, facilitating a direct path through the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, JAKE MINH | 1 | 41.1% | +27.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17209921 | ANTIBIOTIC ELUTING POLY(ESTER UREA) FILMS, MESHES AND POUCHES FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES | VU, JAKE MINH | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17209921 | ANTIBIOTIC ELUTING POLY(ESTER UREA) FILMS, MESHES AND POUCHES FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES | VU, JAKE MINH | 1618 | §103Other | Final Rejection | — | Pending | Mar 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial